DailyDoctor Archive Specialties Get app
All emergency & critical care briefings

The edition · Emergency & Critical Care

Stop measuring gastric residual volumes in ventilated children

A 4,700-child noninferiority trial across 24 paediatric intensive care units found dropping routine six-hourly checks did no harm and improved feeding. Plus a negative trial of MRSA nares swabs for vancomycin de-escalation, a buprenorphine-naloxone licence supplement, lung ultrasound through the oesophagus, and what happens when home beta-blockers are held on admission.

The edition in brief

GASTRIC-PICU randomised 4,700 mechanically ventilated children in 23 UK and one Swiss paediatric intensive care units to routine six-hourly gastric residual volume assessment or no routine assessment, with feed tolerance judged clinically. Not measuring was noninferior for the composite of survival and ventilator-free days at 30 days (adjusted odds ratio 0.95, 95% CI 0.86-1.05) and improved the proportion of energy requirements met by 72 hours from 76.8% to 80.3%. STOP-Vanc randomised 277 adult intensive care patients with suspected community-acquired pneumonia to usual care with or without MRSA nasal PCR: the swab had a negative predictive value of 98.9% but made no difference to vancomycin-free hours alive, an adjusted difference of 4 hours (95% CI -9.5 to 18.2). The FDA has recorded a supplement to a generic buprenorphine and naloxone application held by Dr Reddy's Laboratories. In an observational registry of 379 resuscitative transoesophageal echocardiography studies in ventilated adults with shock, adding transoesophageal lung ultrasound raised operator-reported identification of the shock cause from 75.3% to 86.5% at the cost of about 2.5 minutes. A target trial emulation in 4,635 emergency department admissions with suspected infection found continuing chronic oral beta-blockers within 48 hours was associated with lower 90-day mortality (hazard ratio 0.77, 0.61-0.98). Two of these are randomised; the other two are observational and cannot establish cause.

In this edition
01
Clinical update

GASTRIC-PICU: routine gastric residual checks can go

Stop routine six-hourly gastric residual volume assessment in ventilated children: it was noninferior for survival and ventilator-free days and children met their energy targets sooner without it.

2 min · JAMARead →
Primary outcome
composite of survival and ventilator-free days at 30 days (noninferiority); percentage meeting energy requirements by 72 hours (superiority)
Effect
median 25 ventilator-free days in both arms, adjusted OR 0.95 (95% CI 0.86-1.05); energy requirements met 80.3% versus 76.8%, adjusted difference 3.2 points (1.3-5.2), p<0.001
02Clinical update

A near-perfect test that changed no prescribing

MRSA nasal PCR reliably excludes MRSA pneumonia but did not by itself reduce vancomycin use — the test needs a de-escalation process attached to it.

2 min · Clinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaRead →
03Regulatory

Generic buprenorphine-naloxone supplement recorded by the FDA

The buprenorphine-naloxone entry is generic licence maintenance with no clinical consequence — the useful question is whether your department stocks it and has somewhere to refer.

1 minRead →
04Research

Lung ultrasound through the oesophagus during resuscitative TEE

Adding lung views to resuscitative transoesophageal echocardiography is quick and safe and made operators more confident of the cause of shock — but no patient outcome was measured.

2 min · Critical care medicineRead →
05Pearl

The lactate that matters is the second one

Judge lactate by its trend at two to four hours rather than by the first value, and treat a lactate that will not fall as a reason to reassess the diagnosis, not to give more fluid.

1 minRead →
06
Practice changer

Holding the home beta-blocker on admission may not be the safe option

Continuing a patient's usual beta-blocker on admission with suspected infection was associated with lower 90-day mortality — enough to stop holding it by reflex in stable patients, not enough to make continuation a rule.

2 min · Critical care medicineRead →
Primary outcome
90-day all-cause mortality, continuation versus non-continuation of oral beta-blocker within 48 hours
Effect
continuation in 25.3%; 90-day mortality HR 0.77 (95% CI 0.61-0.98, p=0.03); in-hospital mortality OR 0.60 (0.30-1.20)

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for emergency & critical care, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free